1 Kearney J, Kennedy NP, Keeling PW, et al. Dietary intakes and adipose tissue levels of linoleic acid in peptic ulcer disease. Br J Nutr, 1989, 62(3): 699 2 Grant HW. Palmer KP, Riermesma RR,et al. Deu denal ulcer is assosiated with low dictary linoleic acid in take. Gut,1990, 33:997 3 Hu Heping, Chen Shibao, Zhang Xiankang. The re serach of effect of esstial fatty acid -linoleic acid in the treatment of duodenal ulcer. Third international work-shop & symposium on therapeutic endoscopy & gas-troenterology Beijing, China, 1994:126 4 Tarnawski A, Hollander D, Krause J,et al. Linoleic acid (dietary essential fatty acid-EFA) cytoprotective for the gastric mucossa. Gastroenterol, 1985, 88(5):1610 5 Grant HW, Palmer KP,Kelly RW, et al. Dietary linoleic acid, gastric acid and prostaglandin secre tion. Gastroenterol, 1988, 94(4):955 6 Schepp W,Steffen B, Ruoff HJ,et al. Modulation of rat gastric mucosal prostaglandin E2 release by dietary linoleic acid: effects on gastric acid secretion and stress-induced mucosal damage. Gastroenterol, 1988, 95(1):18 7 Newman RD, Gitln N,Lacayo EJ,et al. Miso prostil in the treatment of duodenal ulcer refractory to H2-blocker therapy. Am J Med, 1987, 83: (suppl 2A): 27 8 Brand DL,Roufail WM,Thomson ABR,et al, Misoprostil, a synthetic PGE1 analog, in the treatment of duodenal uleers: a multicenter doubleblind study. Dis Dis Sci,1985, 30(Suppl): 147s 9 Wilson DE. Role of prostaglandins in gastroduodenal mucosal protection. J Clin Gastroenterol, 1991, 13(Suppl 1):S65 10 Aase S. Disturbances in the balance between aggre sive and protective factors in the gastric and duodenal mucosal. Scan J Gastroenterol, 1989, 24(Suppl 163):17 |